Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
380.00    0.00 (0.00%)
Bid:
370.00
Ask:
390.00
Spread: 20.00 (5.405%)
Market Cap: £408.45m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Update

1 Oct 2018 16:59

RNS Number : 5966C
Origin Enterprises Plc
01 October 2018
 

 

Directorate Update

1 October 2018

 

Origin Enterprises plc ('Origin' or the 'Company') announces the appointment of Sean Coyle (45) to the Board of the Company with effect from today 1 October 2018, as previously outlined in the regulatory announcements of 7 June 2018 and 26 September 2018. Sean was appointed Chief Financial Officer on 1 September 2018.

 

Full details of his current and past directorships within the last five years are outlined below. None of these entities have any relationship with Origin Enterprises plc.

 

There are no other items requiring disclosure in accordance with Schedule 2(g) of the AIM Rules for Companies or the ESM Rules for Companies. Sean Coyle currently has an interest in 7,000 ordinary shares in Origin.

 

Current Directorships

 

None

 

Past Directorships

Sean Gerard Coyle was a director or partner of the following within the last five years:

 

Steel Eagle Holdings, Inc

Dull Investment Corporation

Sharp Clinical Services Incorporated

Sharp Corporation

Ashfield Healthcare Communications, LLC

Ballina Pharma Inc

Magna Healthcare Inc

Ashfield Healthcare LLC

UDG Healthcare Limited

UDG Healthcare UK (Holdco) Limited

Mantis Surgical Limited

Mediscope Limited

Barclay (Northern Ireland) Limited

Klondyke Enterprises Limited

Mansett Limited

Network Hospital Services Limited

Robert Smith & Co. (Derry) Limited

Vector Scientific Limited

Intraveno (N.I.) Limited

New Splint Limited

Unitech Equipment Limited

TD Packaging Limited

Ashfield Alliance Limited

Ashfield Healthcare (Ireland) Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

Dugdale Trading Limited

Marker (U.D.) Ireland Limited

Oremelt Company Unlimited Company

Pharmexx Ireland (Sales Solutions) Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare Nordic Limited

UDG Healthcare Packaging Group Limited

UDG Healthcare Property Holdings Limited

United Care Limited

Aquilant Analytical Sciences Limited

Aquilant Endoscopy Limited

Aquilant Limited

Aquilant Medical (ROI) Limited

Aquilant Nederland B.V.

Aquilant Northern Ireland Limited

Aquilant Pharmaceuticals Limited

Aquilant Scientific (ROI) Limited

UDG Healthcare Specialist Product Services Limited

Alchem Plc

Pemberton Marketing Limited

Magir Limited

UDG Healthcare Distributors Limited

The Health Insurance Authority

Marker International BV

Magna Finance BV

UniDrug Distribution Group Limited

 

ENDS

 

 

 

 

 

 

Enquiries:

 

Peter Dunne +353 (0)1 563 4965

Company Secretary

Origin Enterprises plc

 

Davy (Nominated Adviser)

Anthony Farrell + 353 (0)1 614 9993

 

 

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs. The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine. Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

 

ESM ticker symbol: OIZ

AIM ticker symbol: OGN

 

Website: www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRBUBDGSUGBGIB
Date   Source Headline
3rd Oct 202511:26 amRNSRe-issue of Treasury Shares
2nd Oct 20252:45 pmRNSRe-issue of Treasury Shares
1st Oct 20251:11 pmRNSRe-issue of Treasury Shares
1st Oct 20257:00 amRNSDirectorate Change
30th Sep 20252:58 pmRNSRe-issue of Treasury Shares
25th Sep 20254:02 pmRNSHolding(s) in Company
25th Sep 20254:02 pmRNSHolding(s) in Company
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
24th Sep 202510:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSFinal Results
22nd Sep 20254:49 pmRNSRe-issue of Treasury Shares
26th Aug 20257:00 amRNSHolding(s) in Company
13th Aug 20255:11 pmRNSHolding(s) in Company
30th Jul 20254:31 pmRNSHolding(s) in Company
26th Jun 202511:23 amRNSCancellation of Treasury Shares
20th Jun 202512:27 pmRNSRe-issue of Treasury Shares
18th Jun 202512:51 pmRNSDirector/PDMR Shareholding
13th Jun 20255:09 pmRNSRe-issue of Treasury Shares
13th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSQ3 Trading Update
28th May 20254:18 pmRNSHolding(s) in Company
22nd May 20257:00 amRNSHolding(s) in Company
2nd May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20251:41 pmRNSDirector/PDMR Shareholding
29th Apr 20251:33 pmRNSDirector/PDMR Shareholding
29th Apr 20251:32 pmRNSDirector/PDMR Shareholding
24th Apr 20252:58 pmRNSHolding(s) in Company
9th Apr 202511:44 amRNSHolding(s) in Company
4th Apr 20253:34 pmRNSHolding(s) in Company
2nd Apr 20251:53 pmRNSHolding(s) in Company
25th Mar 20254:54 pmRNSHolding(s) in Company
4th Mar 20257:00 amRNSInterim Results Statement
28th Feb 20255:19 pmRNSHolding(s) in Company
26th Feb 20251:13 pmRNSHolding(s) in Company
25th Feb 20253:51 pmRNSHolding(s) in Company
17th Feb 20257:00 amRNSNew five-year €440 million credit facility
5th Feb 20256:12 pmRNSHolding(s) in Company
4th Feb 202511:52 amRNSRe-issue of Treasury Shares
31st Jan 20255:22 pmRNSLong Term Incentive Plan / PDMR Notification
31st Jan 20253:05 pmRNSRe-issue of Treasury Shares
30th Jan 20256:08 pmRNSDirector/PDMR Shareholding
30th Jan 20256:05 pmRNSLong Term Incentive Plan / PDMR Notification
27th Jan 20252:52 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:15 pmRNSHolding(s) in Company
22nd Jan 20257:00 amRNSDirector/PDMR Shareholding
20th Jan 20252:14 pmRNSHolding(s) in Company
16th Jan 20255:13 pmRNSHolding(s) in Company
7th Jan 20252:55 pmRNSDirector/PDMR Shareholding
12th Dec 20242:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.